4.8 Article

TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data

Journal

NATURE METHODS
Volume 18, Issue 6, Pages 627-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41592-021-01142-2

Keywords

-

Funding

  1. NIH [U01CA226196]
  2. China Scholarship Council

Ask authors/readers for more resources

TRUST4 is an open-source algorithm for reconstructing immune receptor repertoires in alpha beta/gamma delta T cells and B cells, supporting both FASTQ and BAM format, and being faster and more sensitive in assembling full-length receptor repertoires. It can also call repertoire sequences from single-cell RNA-seq data and is compatible with various sequencing platforms.
We introduce the TRUST4 open-source algorithm for reconstruction of immune receptor repertoires in alpha beta/gamma delta T cells and B cells from RNA-sequencing (RNA-seq) data. Compared with competing methods, TRUST4 supports both FASTQ and BAM format and is faster and more sensitive in assembling longer-even full-length-receptor repertoires. TRUST4 can also call repertoire sequences from single-cell RNA-seq (scRNA-seq) data without V(D)J enrichment, and is compatible with both SMART-seq and 5 ' 10x Genomics platforms. TRUST4 is a computational tool for reconstructing T-cell and B-cell receptor repertoires using bulk and single-cell RNA-seq data.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies

Li Song, Zhangyi Ouyang, David Cohen, Yang Cao, Jennifer Altreuter, Gali Bai, Xihao Hu, Kenneth J. Livak, Heng Li, Ming Tang, Bo Li, X. Shirley Liu

Summary: This study utilized the TRUST4 algorithm to analyze thousands of RNA sequencing samples, revealing a strong correlation between CCL5 and MZB1 with T-cell and B-cell clonal expansion. The research also uncovered tyrosine as the preferred residue during B-cell receptor somatic hypermutation, as well as the association of IgG1+IgG3 antibodies with FcRn. Additionally, B-cell clonal expansion and IgG1+IgG3 antibodies were found to be correlated with better patient outcomes.

CANCER IMMUNOLOGY RESEARCH (2022)

No Data Available